Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-NMMA effects on Migrating Motor Complex
NCT02245165Phase 1Completed
- Sponsor
- Uppsala University
- Start
- Jun 2013
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of NG-monomethyl-L-arginine in gastrointestinal motility disorder (2 arms), sponsored by Uppsala University. Primary endpoint: Effect on phases I-III of the migrating motor complex at 1 year. Started Jun 2013; status: completed.
02
Drugs
NG-monomethyl-L-arginine
03
Conditions
gastrointestinal motility disorder
Beyond the preview
Go deeper on NCT02245165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02245165.